歐普康視(300595.SZ):子公司擬2369.94萬元以受讓股權及增資擴股方式投資於青島澤嘉
格隆匯 8 月 31日丨歐普康視(300595.SZ)公佈,2020年8月31日,公司全資子公司歐普康視投資有限公司(“歐普投資”、“甲方”)與史建俊(“丙方1”)、肖淑娟(“丙方2”)在安徽省合肥市簽訂了《歐普康視投資有限公司與史建俊、肖淑娟關於青島澤嘉生物技術有限公司之投資合作協議》,歐普投資擬以自有資金人民幣2369.94萬元以受讓股權及增資擴股的方式投資於青島澤嘉生物技術有限公司(“青島澤嘉”、“乙方”、“標的公司”)。此次投資完成後,歐普投資將持有乙方51%的股權。
標的公司青島澤嘉生物技術有限公司位於山東省青島市,業務範圍主要在山東中東部地區,主要從事醫療器械銷售業務,並通過設立分公司、投資控股子公司等方式開展眼科診所、視光中心等相關業務,在區域的醫療渠道及終端服務方面具備資源優勢,積累了良好的口碑,盈利能力和增長潛能較強。對標的公司進行投資既是基於公司區域業務佈局的考量,也是公司營銷網絡建設的組成部分,對公司的長期發展規劃具有積極影響。此次投資的資金來源為自有資金。
此次投資合作一方面有利於拓展公司在山東省中東部地區的業務佈局,提升公司的市場份額,增強公司的盈利能力,增加公司的業績;另一方面,公司將藉此契機,加強區域資源整合,擴大公司在當地的行業影響力。此次投資對上市公司未來財務狀況和經營成果具有積極的影響,符合公司的長遠發展戰略和全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.